Rezvilutamide
Rezvilutamide (SHR3680) is an orally available androgen receptor inhibitor that crosses the blood-brain barrier and has antitumor activity.Rezvilutamide (SHR3680) is used in the study of metastatic desmoplasia-resistant prostate cancer.
Product Specifications
CAS Number
1572045-62-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
479.47
Molecular Formula
C22H20F3N3O4S
Notes
Research use only, not for human use.
Receptor
Androgen Receptor
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
SENN16-M 100 µL
Monoclonal anti-Parainfluenza type 1 (HPIV-1) nucelocapsid protein IgG
Sign In for Pricing
View Details